WHO, Yobe launch HPVV campaign, targets female children 

The World Health Organisation (WHO) with funding from Canada’s Global Initiative for Vaccine Equity (CanGIVE) Tuesday supported the Yobe government to commence Human Papilloma Virus Vaccine (HPVV) campaign against dangerous killer diseases and cervical cancer for females children between aged  9 – 14 years.

Speaking at the flagging off of the campaign in Damaturu,Yobe state coordinator, WHO, Dr Alhassan Hamisu Dama,  said cervical cancer is the second most common cause of cancer death among women aged 15- 49 years in Nigeria, contributing an estimated 12,075 new cases of global cervical cancer every year. 

Represented by Dr. Habeed Olowu Yinka, Dr Hamisu stated that the Human HPV infection has been identified as a high-risk factor implicated in 95% of cervical cancer. Studies also show that vaccination against HPV infection can reduce incidence by 83% among girls aged 13-19 years.

“As we flag-off this campaign, 565 schools and community teams will work across Yobe state to vaccinate girls aged 9-14 years across schools and out of school camps in Yobe state for the next five days.

“From the pre-implementation trainings at the national, state, LGA and ward levels to implementation and post-implementation activities including post campaign spot-checks, WHO will be spending over 50,000 USD to ensure Yobe state successfully conduct this campaign,” said the WHO Yobe coordinator.

Dr. Hamisu further stated that, this is in addition to their support to the on-going response to the CSM and the residual Diphtheria outbreak and other routine support to the state.

“I want to  say  as the global technical lead for health, we will continue to support every effort of Yobe state government in improving the health and wellbeing of its people,” the WHO coordinator stated.